The use of antibiotics actinomycin D and distamycin A for mapping of phage lambda HindIII fragments

A method to measure the rates of cleavage of specific sites in DNAs by restriction endonucleases is described. Partial digests are prepared by incubating DNAs with limiting amounts of endonuclease. The termini generated by cleavage are labeled with 32P by the polynucleotide kinase-exchange reaction. The labeled termini are then identified by completing the digestion with the same endonuclease and separating the products by gel electrophoresis. As the products of complete digestion of DNA are often easily separated and can be unequivocally identified, this procedure permits comparison of the rates of cleavage of specific sites in DNAs; furthermore, because detection of the products of cleavage utilizes radioautography and does not depend upon their size, or amount, only small amounts of DNA need to be utilized. This method has been used to examine the cleavage of phage lambda DNA by EcoRI endonuclease, and to demonstrate that 5-bromouracil substitution in phage P22 DNA reduces the rate of cleavage of most sites by HindIII endonuclease approximately threefold and the rate of cleavage of one site approximately tenfold.

show abstract

Variation in the inhibition of restriction enzyme cleavage of lambda phage DNA produced by two covalent binding antitumor agents: Anthramycin and mitomycin C

Kaplan

1982

Biochemical and Biophysical Research Communications

View full text Add to dashboard Cite

The use of antibiotics actinomycin D and distamycin A for mapping of phage lambda HindIII fragments

Cited by 12 publications

References 8 publications

Deuterium NMR Studies of Dynamics in Solids

Deuterium NMR Studies of Dynamics in Solids

An assay for the rates of cleavage of specific sites in DNA by restriction endonucleases: Its use to study the cleavage of phage λ DNA by EcoRI and phage P22 DNA containing thymine or 5-bromouracil by HindIII

Variation in the inhibition of restriction enzyme cleavage of lambda phage DNA produced by two covalent binding antitumor agents: Anthramycin and mitomycin C

Contact Info

Product

Resources

About